Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Current Deferred Revenue (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Current Deferred Revenue data on record, last reported at $4.3 million in Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 30.41% year-over-year to $4.3 million; the TTM value through Oct 2025 reached $4.3 million, down 30.41%, while the annual FY2025 figure was $6.1 million, 38.84% up from the prior year.
  • Current Deferred Revenue reached $4.3 million in Q4 2025 per KEQU's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $14.1 million in Q3 2022 and bottomed at $2.6 million in Q3 2021.
  • Average Current Deferred Revenue over 5 years is $5.7 million, with a median of $4.9 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: soared 452.49% in 2022, then tumbled 56.84% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $3.1 million in 2021, then soared by 273.46% to $11.4 million in 2022, then crashed by 56.84% to $4.9 million in 2023, then grew by 26.83% to $6.2 million in 2024, then tumbled by 30.41% to $4.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $4.3 million in Q4 2025, $5.0 million in Q3 2025, and $6.1 million in Q2 2025.